Personal care major Johnson & Johnson is working with biotech specialist Sequential Skin to investigate whether there are any new markers for skin health, particularly those linked to acne and ageing.
Personal care major Johnson & Johnson (J&J) has reported a net profit dip for the full year and last quarter of 2022 amidst ongoing macroeconomic challenges, though its CEO remains focused on heavy R&D investment.
International beauty majors L’Oréal and Johnson & Johnson have launched smart beauty innovations in lipstick, brow care and skin supplements at this year’s CES tech tradeshow.
We round up our most-read stories on the big-name beauty brands in the region, featuring news updates from Amorepacific, Hindustan Unilever, L’Oréal and more.
Personal care major Johnson & Johnson (J&J) has reported a rise in first half (H1) sales for 2022 despite a dip in pre-adjusted profits and consumer health sales hit by COVID-19, input costs and supply issues.
Johnson & Johnson (J&J) will become more competitive in personal care after the carve out of its consumer health business, particularly if it invests in personalised and premium NPD, an analyst says.
Personal care titan Johnson & Johnson (J&J) will split out its consumer health business to create a new publicly traded company, part of its wider plan to pursue more targeted growth strategies.
Personal care major Johnson & Johnson (J&J) has reported a global sales rise for the first quarter of 2021, fuelled by pharmaceuticals and medical devices, but its consumer health division saw overall sales decline despite strength in oral and...
Japanese derma beauty brand Dr.Ci:Labo is aiming to expand the brand’s international presence via the travel retail channel on the back of the heightened awareness of safety and health.
Personal care major Johnson & Johnson has reported a lift in sales for its third quarter thanks to growth in its consumer health division, drawing the firm out of its previous Q2 plunge.
Next month, the multinational health and CPG company is launching a series of webinars highlighting Black expertise and innovation in the skin health industry, and, in a separate initiative will award scholarships to early-career women STEM professors.
The ongoing coronavirus (COVID-19) pandemic has changed the face of beauty business as we know it, and a dig into the financials shows some majors and categories have weathered the storm better than others.
The announcement comes less than one month after a judge’s ruling opened the door to thousands of lawsuits against the multinational medical and CPG company; but Johnson & Johnson attributes the decision to a COVID-19 portfolio assessment.
A ruling this week from US District Judge Freda Wolfson in New Jersey allows testimony from plaintiffs’ medical and scientific experts, including specialists in gynecologic oncology, cancer prevention research, and occupational and environmental health....
Personal care major Johnson & Johnson has lowered its 2020 guidance to reflect the impact of the ongoing coronavirus (COVID-19) crisis, despite a strong net income surge for the first quarter.
Personal care major Johnson & Johnson has reported stable full-year 2019 results, with marginal growth in consumer health driven largely by Neutrogena innovation despite a sales dip in baby care.
Skin scientists from Johnson & Johnson, Proctor & Gamble, and Shiseido have deliberated the future trends and challenges shaping the cosmetics market in Asia Pacific, with personalisation, holistic products and protection identified as major opportunities.
Japanese skin care label Dr. Ci:Labo is tapping into travel retail with a virtual interactive game targeted at Chinese consumers travelling in South Korea.
China-based Hax, which specialises in providing seed investment for hardware startups, has joined forces with personal care giant Johnson & Johnson to create a new acceleration initiative.
After bidding from several prominent global beauty and hair care companies, Vogue will be sold to Johnson & Johnson for just over $3bn in cash, according to an announcement that company made late last week.
The beauty technology segment has been picking up some speed of late and market analyst Kline confirms that creative and price-accessible devices from China have contributed to its record-breaking growth of nearly 15% globally.
Johnson & Johnson is said to be in advanced talks to buy up
Beijing-based Dabao Cosmetics - a move that could give the company
a valuable footing in what is currently a huge growth market.